Last 12 months
Inside the activity.
0 purchase rows · 35 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 2 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 16 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 17 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 25, 2012 Filed May 29, 2012 19:22 UTC |
GLOCER THOMAS HDirector
|
GrantPhantom Stock · Derivative | 3,994.6738 | $37.55 | $150,000.00 |
DisclosureSEC source: 0001225208-12-013300 · doc4.xml · derivative · entry 2 GLOCER THOMAS H · CIK 0001140799 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,276.7968 Underlying: Common Stock · 3,994.6738 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 25, 2012 Filed May 29, 2012 19:22 UTC |
HARRISON WILLIAM B JRDirector
|
GrantPhantom Stock · Derivative | 3,994.6738 | $37.55 | $150,000.00 |
DisclosureSEC source: 0001225208-12-013301 · doc4.xml · derivative · entry 2 HARRISON WILLIAM B JR · CIK 0001179576 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,688.8038 Underlying: Common Stock · 3,994.6738 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 25, 2012 Filed May 29, 2012 19:22 UTC |
KIDDER C ROBERTDirector
|
GrantPhantom Stock · Derivative | 3,994.6738 | $37.55 | $150,000.00 |
DisclosureSEC source: 0001225208-12-013302 · doc4.xml · derivative · entry 3 KIDDER C ROBERT · CIK 0001179703 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,935.0308 Underlying: Common Stock · 3,994.6738 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 25, 2012 Filed May 29, 2012 19:22 UTC |
RUSSO PATRICIA FDirector
|
GrantPhantom Stock · Derivative | 3,994.6738 | $37.55 | $150,000.00 |
DisclosureSEC source: 0001225208-12-013303 · doc4.xml · derivative · entry 2 RUSSO PATRICIA F · CIK 0001023219 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,935.0288 Underlying: Common Stock · 3,994.6738 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 25, 2012 Filed May 29, 2012 19:22 UTC |
Thompson Craig B.Director
|
GrantPhantom Stock · Derivative | 3,994.6738 | $37.55 | $150,000.00 |
DisclosureSEC source: 0001225208-12-013304 · doc4.xml · derivative · entry 2 Thompson Craig B. · CIK 0001423419 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,935.0298 Underlying: Common Stock · 3,994.6738 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 25, 2012 Filed May 29, 2012 19:22 UTC |
WEEKS WENDELL PDirector
|
GrantPhantom Stock · Derivative | 3,994.6738 | $37.55 | $150,000.00 |
DisclosureSEC source: 0001225208-12-013305 · doc4.xml · derivative · entry 3 WEEKS WENDELL P · CIK 0001206158 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,720.0548 Underlying: Common Stock · 3,994.6738 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 25, 2012 Filed May 29, 2012 19:22 UTC |
Wendell Peter CDirector
|
GrantPhantom Stock · Derivative | 3,994.6738 | $37.55 | $150,000.00 |
DisclosureSEC source: 0001225208-12-013306 · doc4.xml · derivative · entry 2 WENDELL PETER C · CIK 0001032635 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,108.0368 Underlying: Common Stock · 3,994.6738 shares Expires not disclosed F1 · derivative.exercise_price: 1-for-1 F2 · derivative.exercise_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F2 · derivative.expiration_date: Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. F3 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| May 10, 2012 Filed May 10, 2012 19:05 UTC |
Bowles Richard S IIIExe VP&Chief Ethics & ComplOff
|
Exercise / conversionStock Option (right to buy) · Derivative | 27,377 | $0.00 Strike: $20.66 | $0.00 |
DisclosureSEC source: 0001225208-12-011833 · doc4.xml · derivative · entry 5 Bowles Richard S III · CIK 0001475384 · Exe VP&Chief Ethics & ComplOff 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 27,377 shares Expires 2015-04-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 10, 2012 Filed May 10, 2012 19:05 UTC |
Bowles Richard S IIIExe VP&Chief Ethics & ComplOff
|
SaleCommon Stock | 27,377 | $38.50 | $1,054,014.50 |
DisclosureSEC source: 0001225208-12-011833 · doc4.xml · nonDerivative · entry 2 Bowles Richard S III · CIK 0001475384 · Exe VP&Chief Ethics & ComplOff 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,540 Read SEC document |
| May 10, 2012 Filed May 10, 2012 19:05 UTC |
Bowles Richard S IIIExe VP&Chief Ethics & ComplOff
|
Exercise / conversionCommon Stock | 27,377 | $20.66 | $565,608.82 |
DisclosureSEC source: 0001225208-12-011833 · doc4.xml · nonDerivative · entry 1 Bowles Richard S III · CIK 0001475384 · Exe VP&Chief Ethics & ComplOff 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,917 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 02, 2012 Filed May 4, 2012 13:39 UTC |
AMBROSE ADELE DSr.V-P & Chief Comuns Officer
|
GrantStock Option (right to buy) · Derivative | 36,563 | $0.00 Strike: $39.29 | $0.00 |
DisclosureSEC source: 0001225208-12-011179 · doc4.xml · derivative · entry 3 AMBROSE ADELE D · CIK 0001182424 · Sr.V-P & Chief Comuns Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,563 Underlying: Common Stock · 36,563 shares Expires 2022-05-01 F3 · derivative.exercise_date: The option vests in three equal annual installments beginning May 2, 2013. Read SEC document |
| May 02, 2012 Filed May 4, 2012 13:39 UTC |
AMBROSE ADELE DSr.V-P & Chief Comuns Officer
|
GrantRestricted Stock Unit · Derivative | 3,818 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-12-011179 · doc4.xml · derivative · entry 2 AMBROSE ADELE D · CIK 0001182424 · Sr.V-P & Chief Comuns Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,818 Underlying: Common Stock · 3,818 shares Expires 2015-05-02 F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. Read SEC document |
| May 02, 2012 Filed May 4, 2012 13:39 UTC |
Canan JohnSr.V-P Finc-Global Controller
|
GrantStock Option (right to buy) · Derivative | 43,876 | $0.00 Strike: $39.29 | $0.00 |
DisclosureSEC source: 0001225208-12-011180 · doc4.xml · derivative · entry 4 Canan John · CIK 0001374366 · Sr.V-P Finc-Global Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,876 Underlying: Common Stock · 43,876 shares Expires 2022-05-01 F4 · derivative.exercise_date: The option vests in three equal annual installments beginning May 2, 2013. Read SEC document |
| May 02, 2012 Filed May 4, 2012 13:39 UTC |
Canan JohnSr.V-P Finc-Global Controller
|
GrantRestricted Stock Unit · Derivative | 4,581 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-12-011180 · doc4.xml · derivative · entry 3 Canan John · CIK 0001374366 · Sr.V-P Finc-Global Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,581 Underlying: Common Stock · 4,581 shares Expires 2015-05-02 F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. Read SEC document |
| May 02, 2012 Filed May 4, 2012 13:39 UTC |
Deese Willie AExe V-P & Pres. MMD
|
GrantStock Option (right to buy) · Derivative | 109,689 | $0.00 Strike: $39.29 | $0.00 |
DisclosureSEC source: 0001225208-12-011181 · doc4.xml · derivative · entry 4 Deese Willie A · CIK 0001328766 · Exe V-P & Pres. MMD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,689 Underlying: Common Stock · 109,689 shares Expires 2022-05-01 F4 · derivative.exercise_date: The option vests in three equal annual installments beginning May 2, 2013. Read SEC document |
| May 02, 2012 Filed May 4, 2012 13:39 UTC |
Deese Willie AExe V-P & Pres. MMD
|
GrantRestricted Stock Unit · Derivative | 7,636 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-12-011181 · doc4.xml · derivative · entry 3 Deese Willie A · CIK 0001328766 · Exe V-P & Pres. MMD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,636 Underlying: Common Stock · 7,636 shares Expires 2015-05-02 F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. Read SEC document |
| May 02, 2012 Filed May 4, 2012 13:39 UTC |
DeLuca Richard R.EVP&Pres, Merck Animal Health
|
GrantStock Option (right to buy) · Derivative | 73,126 | $0.00 Strike: $39.29 | $0.00 |
DisclosureSEC source: 0001225208-12-011182 · doc4.xml · derivative · entry 3 DeLuca Richard R. · CIK 0001421339 · EVP&Pres, Merck Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,126 Underlying: Common Stock · 73,126 shares Expires 2022-05-01 F3 · derivative.exercise_date: The option vests in three equal annual installments beginning May 2, 2013. Read SEC document |
| May 02, 2012 Filed May 4, 2012 13:39 UTC |
DeLuca Richard R.EVP&Pres, Merck Animal Health
|
GrantRestricted Stock Unit · Derivative | 5,090 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-12-011182 · doc4.xml · derivative · entry 2 DeLuca Richard R. · CIK 0001421339 · EVP&Pres, Merck Animal Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,090 Underlying: Common Stock · 5,090 shares Expires 2015-05-02 F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. Read SEC document |
| May 02, 2012 Filed May 4, 2012 13:39 UTC |
DO CUONG VEVP & Chief Strategy Officer
|
GrantStock Option (right to buy) · Derivative | 73,126 | $0.00 Strike: $39.29 | $0.00 |
DisclosureSEC source: 0001225208-12-011183 · doc4.xml · derivative · entry 2 Do Cuong V · CIK 0001477037 · EVP & Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,126 Underlying: Common Stock · 73,126 shares Expires 2022-05-01 F2 · derivative.exercise_date: The option vests in three equal annual installments beginning May 2, 2013. Read SEC document |
| May 02, 2012 Filed May 4, 2012 13:39 UTC |
DO CUONG VEVP & Chief Strategy Officer
|
GrantRestricted Stock Unit · Derivative | 5,090 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-12-011183 · doc4.xml · derivative · entry 1 Do Cuong V · CIK 0001477037 · EVP & Chief Strategy Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,090 Underlying: Common Stock · 5,090 shares Expires 2015-05-02 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. Read SEC document |
| May 02, 2012 Filed May 4, 2012 13:39 UTC |
FRAZIER KENNETH CDirector · Chairman, President & CEO
|
GrantStock Option (right to buy) · Derivative | 694,698 | $0.00 Strike: $39.29 | $0.00 |
DisclosureSEC source: 0001225208-12-011184 · doc4.xml · derivative · entry 3 FRAZIER KENNETH C · CIK 0001181175 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 694,698 Underlying: Common Stock · 694,698 shares Expires 2022-05-01 F3 · derivative.exercise_date: The option vests in three equal annual installments beginning May 2, 2013. Read SEC document |
| May 02, 2012 Filed May 4, 2012 13:40 UTC |
GRADDICK WEIR MIRIAN MExe V-P, HR
|
GrantStock Option (right to buy) · Derivative | 124,314 | $0.00 Strike: $39.29 | $0.00 |
DisclosureSEC source: 0001225208-12-011185 · doc4.xml · derivative · entry 3 GRADDICK WEIR MIRIAN M · CIK 0001168014 · Exe V-P, HR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 124,314 Underlying: Common Stock · 124,314 shares Expires 2022-05-01 F3 · derivative.exercise_date: The option vests in three equal annual installments beginning May 2, 2013. Read SEC document |
| May 02, 2012 Filed May 4, 2012 13:40 UTC |
GRADDICK WEIR MIRIAN MExe V-P, HR
|
GrantRestricted Stock Unit · Derivative | 8,654 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-12-011185 · doc4.xml · derivative · entry 2 GRADDICK WEIR MIRIAN M · CIK 0001168014 · Exe V-P, HR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,654 Underlying: Common Stock · 8,654 shares Expires 2015-05-02 F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. Read SEC document |
| May 02, 2012 Filed May 4, 2012 13:40 UTC |
Heller Bridgette PExe.VP & Pres.Con.Hlth.Care
|
GrantStock Option (right to buy) · Derivative | 80,439 | $0.00 Strike: $39.29 | $0.00 |
DisclosureSEC source: 0001225208-12-011186 · doc4.xml · derivative · entry 2 Heller Bridgette P · CIK 0001485616 · Exe.VP & Pres.Con.Hlth.Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,439 Underlying: Common Stock · 80,439 shares Expires 2022-05-01 F2 · derivative.exercise_date: The option vests in three equal annual installments beginning May 2, 2013. Read SEC document |
| May 02, 2012 Filed May 4, 2012 13:40 UTC |
Heller Bridgette PExe.VP & Pres.Con.Hlth.Care
|
GrantRestricted Stock Unit · Derivative | 5,599 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-12-011186 · doc4.xml · derivative · entry 1 Heller Bridgette P · CIK 0001485616 · Exe.VP & Pres.Con.Hlth.Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,599 Underlying: Common Stock · 5,599 shares Expires 2015-05-02 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. Read SEC document |
| May 02, 2012 Filed May 4, 2012 13:40 UTC |
KELLOGG PETER NExe V-P & CFO
|
GrantStock Option (right to buy) · Derivative | 234,004 | $0.00 Strike: $39.29 | $0.00 |
DisclosureSEC source: 0001225208-12-011187 · doc4.xml · derivative · entry 3 KELLOGG PETER N · CIK 0001226287 · Exe V-P & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 234,004 Underlying: Common Stock · 234,004 shares Expires 2022-05-01 F3 · derivative.exercise_date: The option vests in three equal annual installments beginning May 2, 2013. Read SEC document |
| May 02, 2012 Filed May 4, 2012 13:40 UTC |
KELLOGG PETER NExe V-P & CFO
|
GrantRestricted Stock Unit · Derivative | 16,289 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-12-011187 · doc4.xml · derivative · entry 2 KELLOGG PETER N · CIK 0001226287 · Exe V-P & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,289 Underlying: Common Stock · 16,289 shares Expires 2015-05-02 F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. Read SEC document |
| May 02, 2012 Filed May 4, 2012 13:40 UTC |
Kuhlik Bruce NExe V-P & Gen Counsel
|
GrantStock Option (right to buy) · Derivative | 168,190 | $0.00 Strike: $39.29 | $0.00 |
DisclosureSEC source: 0001225208-12-011188 · doc4.xml · derivative · entry 3 Kuhlik Bruce N · CIK 0001408181 · Exe V-P & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 168,190 Underlying: Common Stock · 168,190 shares Expires 2022-05-01 F3 · derivative.exercise_date: The option vests in three equal annual installments beginning May 2, 2013. Read SEC document |
| May 02, 2012 Filed May 4, 2012 13:40 UTC |
Kuhlik Bruce NExe V-P & Gen Counsel
|
GrantRestricted Stock Unit · Derivative | 11,708 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-12-011188 · doc4.xml · derivative · entry 2 Kuhlik Bruce N · CIK 0001408181 · Exe V-P & Gen Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,708 Underlying: Common Stock · 11,708 shares Expires 2015-05-02 F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. Read SEC document |
| May 02, 2012 Filed May 4, 2012 13:40 UTC |
Rosenblatt MichaelExec V-P & Chief Med Officer
|
GrantStock Option (right to buy) · Derivative | 54,845 | $0.00 Strike: $39.29 | $0.00 |
DisclosureSEC source: 0001225208-12-011189 · doc4.xml · derivative · entry 2 Rosenblatt Michael · CIK 0001478797 · Exec V-P & Chief Med Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,845 Underlying: Common Stock · 54,845 shares Expires 2022-05-01 F2 · derivative.exercise_date: The option vests in three equal annual installments beginning May 2, 2013. Read SEC document |
| May 02, 2012 Filed May 4, 2012 13:40 UTC |
Rosenblatt MichaelExec V-P & Chief Med Officer
|
GrantRestricted Stock Unit · Derivative | 3,818 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-12-011189 · doc4.xml · derivative · entry 1 Rosenblatt Michael · CIK 0001478797 · Exec V-P & Chief Med Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,818 Underlying: Common Stock · 3,818 shares Expires 2015-05-02 F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. Read SEC document |
| May 02, 2012 Filed May 4, 2012 13:40 UTC |
Scalet J ChrisExe V-P Global Srvs & CIO
|
GrantStock Option (right to buy) · Derivative | 73,126 | $0.00 Strike: $39.29 | $0.00 |
DisclosureSEC source: 0001225208-12-011190 · doc4.xml · derivative · entry 4 Scalet J Chris · CIK 0001348912 · Exe V-P Global Srvs & CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,126 Underlying: Common Stock · 73,126 shares Expires 2022-05-01 F4 · derivative.exercise_date: The option vests in three equal annual installments beginning May 2, 2013. Read SEC document |
| May 02, 2012 Filed May 4, 2012 13:40 UTC |
Scalet J ChrisExe V-P Global Srvs & CIO
|
GrantRestricted Stock Unit · Derivative | 5,090 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-12-011190 · doc4.xml · derivative · entry 3 Scalet J Chris · CIK 0001348912 · Exe V-P Global Srvs & CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,090 Underlying: Common Stock · 5,090 shares Expires 2015-05-02 F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. Read SEC document |
| May 02, 2012 Filed May 4, 2012 13:40 UTC |
Schechter Adam HEVP & Pres-Global Human Health
|
GrantStock Option (right to buy) · Derivative | 277,879 | $0.00 Strike: $39.29 | $0.00 |
DisclosureSEC source: 0001225208-12-011191 · doc4.xml · derivative · entry 5 Schechter Adam H · CIK 0001376841 · EVP & Pres-Global Human Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 277,879 Underlying: Common Stock · 277,879 shares Expires 2022-05-01 F4 · derivative.exercise_date: The option vests in three equal annual installments beginning May 2, 2013. Read SEC document |
| May 02, 2012 Filed May 4, 2012 13:40 UTC |
Schechter Adam HEVP & Pres-Global Human Health
|
GrantRestricted Stock Unit · Derivative | 19,343 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-12-011191 · doc4.xml · derivative · entry 4 Schechter Adam H · CIK 0001376841 · EVP & Pres-Global Human Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,343 Underlying: Common Stock · 19,343 shares Expires 2015-05-02 F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. Read SEC document |
| May 02, 2012 Filed May 4, 2012 13:40 UTC |
KIM PETER SExe V-P & Pres, MRL
|
GrantStock Option (right to buy) · Derivative | 219,378 | $0.00 Strike: $39.29 | $0.00 |
DisclosureSEC source: 0001225208-12-011192 · doc4.xml · derivative · entry 4 KIM PETER S · CIK 0001181180 · Exe V-P & Pres, MRL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 219,378 Underlying: Common Stock · 219,378 shares Expires 2022-05-01 F4 · derivative.exercise_date: The option vests in three equal annual installments beginning May 2, 2013. Read SEC document |
| May 02, 2012 Filed May 4, 2012 13:40 UTC |
KIM PETER SExe V-P & Pres, MRL
|
GrantRestricted Stock Unit · Derivative | 15,271 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-12-011192 · doc4.xml · derivative · entry 3 KIM PETER S · CIK 0001181180 · Exe V-P & Pres, MRL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,271 Underlying: Common Stock · 15,271 shares Expires 2015-05-02 F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. Read SEC document |
| May 02, 2012 Filed May 4, 2012 13:40 UTC |
KIM PETER SExe V-P & Pres, MRL
|
GiftCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-12-011192 · doc4.xml · nonDerivative · entry 1 KIM PETER S · CIK 0001181180 · Exe V-P & Pres, MRL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 170,705.9037 F1 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| April 24, 2012 Filed Apr 26, 2012 19:30 UTC |
AMBROSE ADELE DSr.V-P & Chief Comuns Officer
|
Exercise / conversionRSU - Leader Shares · Derivative | 9,000 | $38.27 | $344,430.00 |
DisclosureSEC source: 0001225208-12-010293 · doc4.xml · derivative · entry 3 AMBROSE ADELE D · CIK 0001182424 · Sr.V-P & Chief Comuns Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,000 shares Expires 2012-04-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. Read SEC document |
| April 24, 2012 Filed Apr 26, 2012 19:30 UTC |
AMBROSE ADELE DSr.V-P & Chief Comuns Officer
|
Tax withholdingCommon Stock | 3,272 | $38.27 | $125,219.44 |
DisclosureSEC source: 0001225208-12-010293 · doc4.xml · nonDerivative · entry 2 AMBROSE ADELE D · CIK 0001182424 · Sr.V-P & Chief Comuns Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,039.292 F1 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| April 24, 2012 Filed Apr 26, 2012 19:30 UTC |
AMBROSE ADELE DSr.V-P & Chief Comuns Officer
|
Exercise / conversionCommon Stock | 9,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-12-010293 · doc4.xml · nonDerivative · entry 1 AMBROSE ADELE D · CIK 0001182424 · Sr.V-P & Chief Comuns Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,311.292 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 24, 2012 Filed Apr 26, 2012 19:30 UTC |
Canan JohnSr.V-P Finc-Global Controller
|
Exercise / conversionRestricted Stock Unit · Derivative | 5,775 | $38.27 | $221,009.25 |
DisclosureSEC source: 0001225208-12-010294 · doc4.xml · derivative · entry 4 Canan John · CIK 0001374366 · Sr.V-P Finc-Global Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,775 shares Expires 2012-04-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. Read SEC document |
| April 24, 2012 Filed Apr 26, 2012 19:30 UTC |
Canan JohnSr.V-P Finc-Global Controller
|
Tax withholdingCommon Stock | 2,100 | $38.27 | $80,367.00 |
DisclosureSEC source: 0001225208-12-010294 · doc4.xml · nonDerivative · entry 2 Canan John · CIK 0001374366 · Sr.V-P Finc-Global Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,106.351 F1 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| April 24, 2012 Filed Apr 26, 2012 19:30 UTC |
Canan JohnSr.V-P Finc-Global Controller
|
Exercise / conversionCommon Stock | 5,775 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-12-010294 · doc4.xml · nonDerivative · entry 1 Canan John · CIK 0001374366 · Sr.V-P Finc-Global Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,206.351 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 24, 2012 Filed Apr 26, 2012 19:30 UTC |
GRADDICK WEIR MIRIAN MExe V-P, HR
|
Exercise / conversionRestricted Stock Unit · Derivative | 11,700 | $38.27 | $447,759.00 |
DisclosureSEC source: 0001225208-12-010295 · doc4.xml · derivative · entry 3 GRADDICK WEIR MIRIAN M · CIK 0001168014 · Exe V-P, HR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,700 shares Expires 2012-04-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. Read SEC document |
| April 24, 2012 Filed Apr 26, 2012 19:30 UTC |
GRADDICK WEIR MIRIAN MExe V-P, HR
|
Tax withholdingCommon Stock | 4,253 | $38.27 | $162,762.31 |
DisclosureSEC source: 0001225208-12-010295 · doc4.xml · nonDerivative · entry 2 GRADDICK WEIR MIRIAN M · CIK 0001168014 · Exe V-P, HR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,794.024 F1 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| April 24, 2012 Filed Apr 26, 2012 19:30 UTC |
GRADDICK WEIR MIRIAN MExe V-P, HR
|
Exercise / conversionCommon Stock | 11,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-12-010295 · doc4.xml · nonDerivative · entry 1 GRADDICK WEIR MIRIAN M · CIK 0001168014 · Exe V-P, HR 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,047.024 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 24, 2012 Filed Apr 26, 2012 19:30 UTC |
KELLOGG PETER NExe V-P & CFO
|
Exercise / conversionRestricted Stock Unit · Derivative | 17,550 | $38.27 | $671,638.50 |
DisclosureSEC source: 0001225208-12-010296 · doc4.xml · derivative · entry 3 KELLOGG PETER N · CIK 0001226287 · Exe V-P & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 17,550 shares Expires 2012-04-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock. Read SEC document |
| April 24, 2012 Filed Apr 26, 2012 19:30 UTC |
KELLOGG PETER NExe V-P & CFO
|
Tax withholdingCommon Stock | 8,135 | $38.27 | $311,326.45 |
DisclosureSEC source: 0001225208-12-010296 · doc4.xml · nonDerivative · entry 2 KELLOGG PETER N · CIK 0001226287 · Exe V-P & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,482.902 F1 · balance_after: Holdings include shares acquired in dividend reinvestment transactions. Read SEC document |
| April 24, 2012 Filed Apr 26, 2012 19:30 UTC |
KELLOGG PETER NExe V-P & CFO
|
Exercise / conversionCommon Stock | 17,550 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-12-010296 · doc4.xml · nonDerivative · entry 1 KELLOGG PETER N · CIK 0001226287 · Exe V-P & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,617.902 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.